Your browser doesn't support javascript.
loading
Performance Characteristics of the Ultrasound Strategy during Incidence Screening in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
Kalsi, Jatinderpal; Gentry-Maharaj, Aleksandra; Ryan, Andy; Singh, Naveena; Burnell, Matthew; Massingham, Susan; Apostolidou, Sophia; Sharma, Aarti; Williamson, Karin; Seif, Mourad; Mould, Tim; Woolas, Robert; Dobbs, Stephen; Leeson, Simon; Fallowfield, Lesley; Skates, Steven J; Parmar, Mahesh; Campbell, Stuart; Jacobs, Ian; McGuire, Alistair; Menon, Usha.
Afiliação
  • Kalsi J; Department of Women's Cancer, Institute for Women's Health, University College London, London WC1E 6HU, UK.
  • Gentry-Maharaj A; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, London WC1V 6LJ, UK.
  • Ryan A; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, London WC1V 6LJ, UK.
  • Singh N; Department of Pathology, Barts and the London, London E1 2ES, UK.
  • Burnell M; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, London WC1V 6LJ, UK.
  • Massingham S; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, London WC1V 6LJ, UK.
  • Apostolidou S; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, London WC1V 6LJ, UK.
  • Sharma A; Department of Obstetrics and Gynaecology, University Hospital of Wales, Cardiff CF14 4XW, UK.
  • Williamson K; Department of Gynaecological Oncology, Nottingham City Hospital, Nottingham NG5 1PB, UK.
  • Seif M; Division of Gynaecology and of Cancer Services, St. Mary's Hospital and University of Manchester, Manchester M13 9WL, UK.
  • Mould T; Department of Gynaecological Oncology, University College Hospital, London NW1 2BU, UK.
  • Woolas R; Department of Gynaecological Oncology, Queen Alexandra Hospital, Portsmouth PO6 3LY, UK.
  • Dobbs S; Department of Gynaecological Oncology, Belfast City Hospital, Belfast BT9 7AB, UK.
  • Leeson S; Department of Obstetrics and Gynaecology, Ysbyty Gwynedd, Bangor, Gwynedd LL57 2PW, UK.
  • Fallowfield L; Cancer Research UK Sussex Psychosocial Oncology Group at Brighton & Sussex Medical School, University of Sussex, Falmer BN1 9PX, UK.
  • Skates SJ; Massachusetts General Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Parmar M; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, London WC1V 6LJ, UK.
  • Campbell S; Create Fertility Clinic, London EC2V 6ET, UK.
  • Jacobs I; Department of Women's Cancer, Institute for Women's Health, University College London, London WC1E 6HU, UK.
  • McGuire A; Department of Women's Health, University of New South Wales, Australia, Sydney 2052, Australia.
  • Menon U; London School of Economics and Political Science, London WC2A 2AE, UK.
Cancers (Basel) ; 13(4)2021 Feb 18.
Article em En | MEDLINE | ID: mdl-33670571
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido